Tricida, Inc.   Report issue

For profit Phase 3
Founded: South San Francisco CA United States (2013)

Organization Overview

First Clinical Trial
2016
NCT02809183
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Tricida, Inc.